Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% Minoxidil Foam vs 2% Solution in Female Pattern Hair Loss
NCT01145625Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of minoxidil in Female Pattern Hair Loss (FPHL) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Target Area Hair Count at 24 weeks. Started Jun 2010; status: completed.
02
Drugs
minoxidil
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on NCT01145625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145625.